Schrodinger Inc

NASDAQ:SDGR   3:59:50 PM EDT
31.18
-1.89 (-5.72%)
Products

Schrödinger Announces FDA Clearance Of Investigational New Drug Application For Sgr-1505, A Malt1 Inhibitor

Published: 06/28/2022 11:16 GMT
Schrodinger Inc (SDGR) - SchrÖdinger Announces FDA Clearance of Investigational New Drug Application for Sgr-1505, a Malt1 Inhibitor.
Schrodinger Inc - Phase 1 Clinical Trial in Patients With Advanced B-cell Malignancies Expected to Begin in Second Half of 2022 for Sgr-1505.